# Oncology Today with Dr Neil Love: Optimizing the Management of Tenosynovial Giant Cell Tumor

Page: https://stenobird.com/podcast/dermatologic-oncology-update-450819/oncology-today-with-dr-neil-love-optimizing-the-management-of-tenosynovial-giant-cell-tumor
Text version: https://stenobird.com/podcast/dermatologic-oncology-update-450819/oncology-today-with-dr-neil-love-optimizing-the-management-of-tenosynovial-giant-cell-tumor.md
Podcast: [Dermatologic Oncology Update](https://stenobird.com/podcast/dermatologic-oncology-update-450819)
Published: 2024-11-21T16:24:00+00:00
Episode link: https://dermatologic.researchtopractice.com/episode/oncology-today-with-dr-neil-love-optimizing-the-management-of-tenosynovial-giant-cell-tumor
Audio file: https://dts.podtrac.com/redirect.mp3/podcasts.captivate.fm/media/1b405a47-e86c-414a-8aae-100961fe2a84/oncologytodaytgct24.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/dermatologic-oncology-update-450819/episodes/oncology-today-with-dr-neil-love-optimizing-the-management-of-tenosynovial-giant-cell-tumor
Duration seconds: 3835

## Resource

Dr Emanuela Palmerini from the IRCCS Istituto Ortopedico Rizzoli in Bologna, Italy, discusses the current and future clinical treatment of tenosynovial giant cell tumor.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/dermatologic-oncology-update-450819/episodes/oncology-today-with-dr-neil-love-optimizing-the-management-of-tenosynovial-giant-cell-tumor/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/dermatologic-oncology-update-450819/oncology-today-with-dr-neil-love-optimizing-the-management-of-tenosynovial-giant-cell-tumor.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.